Li Q - Search Results

1

The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment.

Luo H, Wang W, Mai J, Yin R, Cai X, Li Q. Luo H, et al. Among authors: li q. Front Immunol. 2023 Oct 10;14:1267918. doi: 10.3389/fimmu.2023.1267918. eCollection 2023. Front Immunol. 2023. PMID: 37881432 Free PMC article. Review.

2

Development of a personalized dendritic cell vaccine and single-cell RNA sequencing-guided assessment of its cell type composition.

Li Q, Yang C, Tian H, Jiang J, Li P, Zhu X, Lei T, Yin R, Ding P, Bai P, Li Q. Li Q, et al. Among authors: li p. Cytotherapy. 2023 Feb;25(2):210-219. doi: 10.1016/j.jcyt.2022.10.013. Epub 2022 Nov 25. Cytotherapy. 2023. PMID: 36443171 Free article.

3

Therapeutic strategies targeting folate receptor α for ovarian cancer.

Mai J, Wu L, Yang L, Sun T, Liu X, Yin R, Jiang Y, Li J, Li Q. Mai J, et al. Among authors: li j, li q. Front Immunol. 2023 Aug 30;14:1254532. doi: 10.3389/fimmu.2023.1254532. eCollection 2023. Front Immunol. 2023. PMID: 37711615 Free PMC article. Review.

4

[Peripheral Blood Laboratory Test Results Combined with TCF1+CD8+ T Lymphocytes  Ratio to Predict the Response and Prognosis of Immunotherapy to  Advanced Lung Cancer].

Luo H, Dai S, Li Y, Tian P, Li Q, Cai X. Luo H, et al. Among authors: li y, li q. Zhongguo Fei Ai Za Zhi. 2023 Aug 20;26(8):605-614. doi: 10.3779/j.issn.1009-3419.2023.102.29. Zhongguo Fei Ai Za Zhi. 2023. PMID: 37752540 Free PMC article. Chinese.

5

A critical time window for leukapheresis product transportation to manufacture clinical-grade dendritic cells with optimal anti-tumor activities.

Wang W, Jiang J, Yang C, Meng X, Gao L, Yuan Y, Lei T, Ding P, Yin R, Li Q. Wang W, et al. Among authors: li q. Cytotherapy. 2024 Feb;26(2):210-220. doi: 10.1016/j.jcyt.2023.12.003. Epub 2023 Dec 19. Cytotherapy. 2024. PMID: 38127032

6

A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China.

Chen J, Zhang M, Li K, Duan Y, Lin X, Zhong L, Li Q, Yin R. Chen J, et al. Among authors: li k, li q. Front Oncol. 2024 Jan 8;13:1300199. doi: 10.3389/fonc.2023.1300199. eCollection 2023. Front Oncol. 2024. PMID: 38260846 Free PMC article.

7

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China.

Chen J, Zhang M, Li K, Duan Y, Zeng J, Li Q, Wang D, Song L, Li Q, Yin R. Chen J, et al. Among authors: li k, li q. Front Oncol. 2024 Feb 2;14:1336616. doi: 10.3389/fonc.2024.1336616. eCollection 2024. Front Oncol. 2024. PMID: 38371630 Free PMC article.

8

Corrigendum: Therapeutic strategies targeting folate receptor α for ovarian cancer.

Mai J, Wu L, Yang L, Sun T, Liu X, Yin R, Jiang Y, Li J, Li Q. Mai J, et al. Among authors: li j, li q. Front Immunol. 2024 Apr 17;15:1403324. doi: 10.3389/fimmu.2024.1403324. eCollection 2024. Front Immunol. 2024. PMID: 38694498 Free PMC article.

9

A new subtype of Lynch syndrome associated with MSH2 c.354T>A (p. Y118*) identified in a Chinese family: case report and literature review.

Zhong L, Wang W, Duan Y, Song L, Li Z, Yang K, Li Q, Yin R. Zhong L, et al. Among authors: li z, li q. Front Genet. 2024 Oct 7;15:1440179. doi: 10.3389/fgene.2024.1440179. eCollection 2024. Front Genet. 2024. PMID: 39440242 Free PMC article.

10

Extra-cerebral recombination activity of Emx1-Cre and nestin-Cre in the kidney.

Wang M, Liu X, Fang Y, Li Q. Wang M, et al. Among authors: li q. Front Cell Dev Biol. 2024 Oct 16;12:1480217. doi: 10.3389/fcell.2024.1480217. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39479517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,157 results

Search Page

Filters